Testosterone deficiency in men receiving immunotherapy for malignant melanoma

Immunotherapy has been established as a standard of care for patients with malignant melanoma, however, the long-term side-effects of immunotherapy are still emerging. Studies over the last decade have documented increasing reports of endocrine dysfunction following the initiation of immunotherapy....

Descripción completa

Detalles Bibliográficos
Autores principales: Peters, Madeline, Pearlman, Amy, Terry, William, Mott, Sarah L., Monga, Varun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869578/
https://www.ncbi.nlm.nih.gov/pubmed/33613847
http://dx.doi.org/10.18632/oncotarget.27876

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869578/
https://www.ncbi.nlm.nih.gov/pubmed/33613847
http://dx.doi.org/10.18632/oncotarget.27876

Ejemplares similares